Evidence map›Paper›PMID 37693491›Full record

ArticleResearch square2023

Antiretroviral treatment is less effective at reducing gut microbiome-associated inflammation and T cell activation in people living with HIV in rural versus urban Zimbabwe.

Alessandro Lazzaro, Angela Sofia Burkhart Colorado, Charles Preston Neff, Nichole Nusbacher, Kathryn Boyd, Suzanne Fiorillo, Casey Martin, Janet Siebert, Thomas Campbell, Margaret Borok and 2 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 4 countries.

Alessandro LazzaroSapienza University of Rome.
Angela Sofia Burkhart ColoradoUniversity of Colorado Anschutz Medical Campus.
Charles Preston NeffUniversity of Colorado Anschutz Medical Campus.
Nichole NusbacherUniversity of Colorado Anschutz Medical Campus.
Kathryn BoydLondon School of Hygiene & Tropical Medicine.
Suzanne FiorilloUniversity of Colorado Anschutz Medical Campus.
Casey MartinUniversity of Colorado Anschutz Medical Campus.
Janet SiebertUniversity of Colorado Anschutz Medical Campus.
Thomas CampbellUniversity of Colorado Anschutz Medical Campus.
Margaret BorokUniversity of Zimbabwe.
Brent PalmerUniversity of Colorado Anschutz Medical Campus.
Catherine LozuponeUniversity of Colorado Anschutz Medical Campus.
University of Zimbabwe · ZWUniversity of Colorado Anschutz Medical Campus · US

Funding

Computational Bioscience Program Training GrantT15LM009451 · NLM · UNIVERSITY OF COLORADO DENVER · PI Katherina Kechris-Mays, Arjun Krishnan · 2007 to 2026
$11.7M
Diet/gut Microbiome Interaction Influence Inflammatory Disease in HIV PatientsR01DK108366 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI CAMPBELL, THOMAS B., LOZUPONE, CATHERINE · 2015 to 2019
$3.0M
NIDDK NIH HHS R01 DK108366NLM NIH HHS T15 LM009451
6 · The paper itself

Abstract

The widespread availability of antiretroviral therapy (ART) for people living with HIV (PLWH) has dramatically reduced mortality and improved life expectancy. However, even with suppression of HIV-1 replication, chronic immune activation and elevated inflammation persist. Chronic immune activation has been linked to a pro-inflammatory gut microbiome composition, exacerbated by compromised intestinal barrier integrity that occurs after HIV infection. Individuals living in urban versus rural areas of sub-Saharan Africa have differences in environmental factors such as water source or diet that may impact gut microbiome composition, yet immune phenotype and gut microbiome composition response to ART in PLWH living in rural versus urban areas of sub-Saharan Africa have not been compared. Here, we measured immune phenotypes and fecal microbiome composition in PLWH and healthy participants recruited from the urban Mabvuku polyclinic in the city of Harare, Zimbabwe and the Mutoko District hospital located in a district 146 km from Harare that services surrounding rural villages. PLWH were either ART naïve at baseline and sampled again after 24 weeks of treatment with efavirenz/lamivudine/tenofovir disoproxil fumarate (EFV/3TC/TDF) and the prophylactic antibiotic cotrimoxazole or were ART experienced at both timepoints. Although expected reductions in the inflammatory marker IL-6, T-cell activation, and exhaustion were observed in individuals who had suppressed HIV-1 with treatment, these changes were significant only when considering individuals in the urban and not the rural area. Gut microbiome composition showed more marked differences from healthy controls in the ART experienced compared to ART naïve cohort, and consistent longitudinal changes were also observed in ART naïve PLWH after 24 weeks of treatment, including a reduction in alpha diversity and altered composition. However, gut microbiome composition showed a more pronounced relationship with chronic immune activation and exhaustion phenotypes in the ART naïve compared to ART experienced PLWH, suggesting a particularly significant role for the gut microbiome in disease progression in uncontrolled infection.

Indexed as

ART responseHIVimmune activation and exhaustioninflammationintestinal microbiomeruralurban

Identifiers

PMID37693491
PMCPMC10491326
OpenAlexW4386333089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.